LA | |
---|---|
Post | 2.3 |
Pre | 1.0 |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | - | 0.7 | 2.3 | - | - | 3.0 |
1 | - | - | - | - | - | - | 2.7 | 5.0 | - | - | 7.7 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 66.3 |
1 | 137.7 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | - |
1 | - |
Number of post synapses: 9
Number of pre synapses: 23
Number of output connections: 61
Coverage factor: 3.0
Columnar completeness: 0.00
Area completeness: nan
Cell size (columns): 1
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#HBeyelet (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | HBeyelet (R) | His | 139 | 46.3 | 54.3% | 54.3% |
1 | Dm9 (R) | Glu | 40 | 13.3 | 15.6% | 69.9% |
2 | OA-AL2i3 (R) | OA | 38 | 12.7 | 14.8% | 84.8% |
3 | aMe5 (R) | ACh | 14 | 4.7 | 5.5% | 90.2% |
4 | aMe6c (R) | Glu | 9 | 3.0 | 3.5% | 93.8% |
5 | MeVPMe12 (L) | ACh | 5 | 1.7 | 2.0% | 95.7% |
6 | aMe6b (R) | ACh | 4 | 1.3 | 1.6% | 97.3% |
7 | aMe4 (R) | ACh | 3 | 1.0 | 1.2% | 98.4% |
instance | NT | total connections | connections /#HBeyelet (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe6c (R) | Glu | 410 | 136.7 | 22.1% | 22.1% |
1 | aMe6b (R) | ACh | 313 | 104.3 | 16.9% | 39.0% |
2 | aMe6a (R) | ACh | 261 | 87.0 | 14.1% | 53.0% |
3 | aMe3 (R) | Glu | 201 | 67.0 | 10.8% | 63.9% |
4 | HBeyelet (R) | His | 139 | 46.3 | 7.5% | 71.4% |
5 | Dm9 (R) | Glu | 105 | 35.0 | 5.7% | 77.0% |
6 | aMe5 (R) | ACh | 80 | 26.7 | 4.3% | 81.3% |
7 | l-LNv (R) | unclear | 78 | 26.0 | 4.2% | 85.6% |
8 | aMe30 (R) | Glu | 58 | 19.3 | 3.1% | 88.7% |
9 | aMe10 (R) | ACh | 28 | 9.3 | 1.5% | 90.2% |
10 | SLP250 (R) | unclear | 27 | 9.0 | 1.5% | 91.6% |
11 | OA-AL2i3 (R) | OA | 24 | 8.0 | 1.3% | 92.9% |
12 | Cm28 (R) | unclear | 18 | 6.0 | 1.0% | 93.9% |
13 | aMe1 (R) | GABA | 12 | 4.0 | 0.6% | 94.6% |
14 | MeVP43 (R) | ACh | 11 | 3.7 | 0.6% | 95.1% |
15 | aMe4 (R) | ACh | 8 | 2.7 | 0.4% | 95.6% |
16 | LT58 (R) | Glu | 8 | 2.7 | 0.4% | 96.0% |
17 | MeVC21 (R) | Glu | 6 | 2.0 | 0.3% | 96.3% |
18 | Lat5 (R) | unclear | 5 | 1.7 | 0.3% | 96.6% |
19 | MeVC20 (R) | Glu | 5 | 1.7 | 0.3% | 96.9% |
20 | LoVC23 (L) | GABA | 4 | 1.3 | 0.2% | 97.1% |
21 | MeLo7 (R) | ACh | 4 | 1.3 | 0.2% | 97.3% |
22 | aMe12 (R) | ACh | 3 | 1.0 | 0.2% | 97.5% |
23 | aMe2 (R) | Glu | 3 | 1.0 | 0.2% | 97.6% |
24 | CL125 (R) | unclear | 3 | 1.0 | 0.2% | 97.8% |
25 | MeVP40 (R) | unclear | 3 | 1.0 | 0.2% | 98.0% |
26 | Tm5c (R) | Glu | 3 | 1.0 | 0.2% | 98.1% |